 |
 |
10 Nov 2000: Withdrawal of phenylpropanolamine (PPA) products | |
| There was an increased risk of haemorrhagic stroke from the ingestion of PPA, especially with PPA slimming products. PPA is a common decongestant found in combination with other drugs in many cough and cold medicines. |
|
|
|
16 Sep 2000: Suspension of product licence for cisapride-containing medicinal products | |
| Cisapride has been reported to cause QT prolongation and lead to rare but life threatening arrhythmias. |
|
 |
